Publications by authors named "Martin Dunbar"

Claim this Profile
A
Aripiprazole Lauroxil Every 2 Months or Paliperidone Palmitate Monthly for Acute Schizophrenia: A Post Hoc Analysis of PANSS Five-Factor Scores in the ALPINE Trial.
Leslie Citrome, Martin Dunbar, James A McGrory

Neuropsychiatr Dis Treat· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of Schizophrenia.
Leslie Citrome, Christoph U Correll, Andrew J Cutler, Martin Dunbar, Amber R Hoberg

Neuropsychiatr Dis Treat· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Safety, Tolerability, and Durability of Treatment Effect of Olanzapine and Samidorphan: Results of a 4-Year Open-Label Study.
Jacob S Ballon, René S Kahn, Christina Arevalo, Martin Dunbar, David McDonnell

J Clin Psychiatry· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer.
D Ross Camidge, Fabrice Barlesi, Jonathan W Goldman, Daniel Morgensztern, Rebecca Heist, Martin Dunbar

J Clin Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considering Precision and Utility When we Talk About Pain. Comment on Cohen et al.
Graham L Moseley, Neil Pearson, Roland Reezigt, Victoria J Madden, Mark R Hutchinson, Martin Dunbar

J Pain· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review of economic analyses of psychological interventions and therapies in health-related settings.
Leeanne Nicklas, Mairi Albiston, Martin Dunbar, Alan Gillies, Jennifer Hislop

BMC Health Serv Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study.
Patricia LoRusso, Mark J Ratain, Toshihiko Doi, Drew W Rasco, Maja J A de Jonge, Martin Dunbar

Invest New Drugs· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer.
Ramaswamy Govindan, Mike Lind, Amelia Insa, Saad A Khan, Dmitry Uskov, Martin Dunbar

Clin Lung Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1b Study of Telisotuzumab Vedotin in Combination With Nivolumab in Patients With NSCLC.
D Ross Camidge, Fabrice Barlesi, Jonathan W Goldman, Daniel Morgensztern, Rebecca Heist, Martin Dunbar

JTO Clin Res Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study.
Suresh S Ramalingam, Silvia Novello, Salih Zeki Guclu, Dmitry Bentsion, Zanete Zvirbule, Martin Dunbar

J Clin Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Veliparib and nivolumab in combination with platinum doublet chemotherapy in patients with metastatic or advanced non-small cell lung cancer: A phase 1 dose escalation study.
Jeffrey M Clarke, Jyoti D Patel, Francisco Robert, Ebenezer A Kio, Eddie Thara, Martin Dunbar

Lung Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study.
Lauren Averett Byers, Dmitry Bentsion, Steven Gans, Konstantin Penkov, ChoonHee Son, Martin Dunbar

Clin Cancer Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and testing of a checklist to assess compliance with the faculty of pain medicine's core standards for pain management services: experience in a new national tertiary pain service.
Asma M Torkamani, Rachel Atherton, Martin Dunbar, Hamish J McLeod

Br J Pain· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of PARP-inhibitor ABT-767 in advanced solid tumors with BRCA1/2 mutations and high-grade serous ovarian, fallopian tube, or primary peritoneal cancer.
Diane A J van der Biessen, Jourik A Gietema, Maja J A de Jonge, Ingrid M E Desar, Martha W den Hollander, Martin Dunbar

Invest New Drugs· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and pharmacokinetics of veliparib extended-release in patients with advanced solid tumors: a phase I study.
Theresa L Werner, Jasgit Sachdev, Elizabeth M Swisher, Martin Gutierrez, Muaiad Kittaneh, Martin Dunbar

Cancer Med· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study.
Courtney D DiNardo, Keith W Pratz, Anthony Letai, Brian A Jonas, Andrew H Wei, Martin Dunbar

Lancet Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma.
Shaji Kumar, Jonathan L Kaufman, Cristina Gasparetto, Joseph Mikhael, Ravi Vij, Martin Dunbar

Blood· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of venetoclax in patients with 17p deletion chronic lymphocytic leukemia.
Ahmed Hamed Salem, Martin Dunbar, Suresh K Agarwal

Anticancer Drugs· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smoking History Predicts Sensitivity to PARP Inhibitor Veliparib in Patients with Advanced Non-Small Cell Lung Cancer.
Martin Reck, Normand Blais, Erzsebet Juhasz, Vera Gorbunova, C Michael Jones, Martin Dunbar

J Thorac Oncol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Venetoclax, a Novel BCL-2 Inhibitor, in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma.
Ahmed Hamed Salem, Suresh K Agarwal, Martin Dunbar, Sari L Heitner Enschede, Rod A Humerickhouse

J Clin Pharmacol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers to self-management of chronic pain in primary care: a qualitative focus group study.
Katy Gordon, Helen Rice, Nick Allcock, Pamela Bell, Martin Dunbar

Br J Gen Pract· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism and Disposition of a Novel B-Cell Lymphoma-2 Inhibitor Venetoclax in Humans and Characterization of Its Unusual Metabolites.
Hong Liu, Melissa J Michmerhuizen, Yanbin Lao, Katty Wan, Ahmed Hamed Salem, Martin Dunbar

Drug Metab Dispos· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma.
Matthew S Davids, Andrew W Roberts, John F Seymour, John M Pagel, Brad S Kahl, Martin Dunbar

J Clin Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Venetoclax-Posaconazole Interaction in Acute Myeloid Leukemia Patients: Evaluation of Dose Adjustments.
Suresh K Agarwal, Courtney D DiNardo, Jalaja Potluri, Martin Dunbar, Hagop M Kantarjian

Clin Ther· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax does not prolong the QT interval in patients with hematological malignancies: an exposure-response analysis.
Kevin J Freise, Martin Dunbar, Aksana K Jones, David Hoffman, Sari L Heitner Enschede

Cancer Chemother Pharmacol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis